BRPI0914556A2 - Processo para a preparação de compostos de piperazina substituídos por cicloalquila - Google Patents
Processo para a preparação de compostos de piperazina substituídos por cicloalquilaInfo
- Publication number
- BRPI0914556A2 BRPI0914556A2 BRPI0914556-7A BRPI0914556A BRPI0914556A2 BR PI0914556 A2 BRPI0914556 A2 BR PI0914556A2 BR PI0914556 A BRPI0914556 A BR PI0914556A BR PI0914556 A2 BRPI0914556 A2 BR PI0914556A2
- Authority
- BR
- Brazil
- Prior art keywords
- preparation
- cycloalkyl substituted
- substituted piperazine
- piperazine compounds
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
- C07D295/112—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2008/060562 WO2009021944A1 (de) | 2007-08-14 | 2008-08-12 | Neue verbindungen |
| PCT/EP2009/001012 WO2010017850A1 (de) | 2008-08-12 | 2009-02-13 | Verfahren zur herstellung von cycloalkyl-substituierten piperazinverbindungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0914556A2 true BRPI0914556A2 (pt) | 2015-08-04 |
Family
ID=40897303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0914556-7A BRPI0914556A2 (pt) | 2008-08-12 | 2009-02-13 | Processo para a preparação de compostos de piperazina substituídos por cicloalquila |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20110301350A1 (pt) |
| JP (1) | JP2011530544A (pt) |
| KR (1) | KR20110053424A (pt) |
| BR (1) | BRPI0914556A2 (pt) |
| CA (1) | CA2735560A1 (pt) |
| IL (1) | IL210741A0 (pt) |
| MX (1) | MX2011001563A (pt) |
| WO (1) | WO2010017850A1 (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2025675A1 (de) | 2007-08-14 | 2009-02-18 | Boehringer Ingelheim International GmbH | Arylsulfonamide mit analgetischer Wirkung |
| CN104478875B (zh) | 2008-08-06 | 2017-04-12 | 麦迪韦逊科技有限公司 | 聚(adp‑核糖)聚合酶(parp)的二氢吡啶并酞嗪酮抑制剂 |
| EP2531033A4 (en) | 2010-02-03 | 2013-07-31 | Biomarin Pharm Inc | POLY (ADP-RIBOSE) POLYMERASE (PARP) DIHYDROPYRIDOPHTHALAZINE HEMMER FOR USE IN THE TREATMENT OF PTEN-LACK ASSOCIATED DISEASES |
| KR101826652B1 (ko) | 2010-02-08 | 2018-02-07 | 메디베이션 테크놀로지즈, 인크. | 디히드로피리도프탈라지논 유도체의 합성 방법 |
| CN103003253A (zh) | 2010-08-05 | 2013-03-27 | 贝林格尔.英格海姆国际有限公司 | 2-{2-[[(4-甲氧基-2,6-二甲基苯基)磺酰基]-(甲基)氨基]乙氧基}-n-甲基-n-[3-(4-甲基哌嗪-1-基)环己基]乙酰胺的酸加成盐及其作为缓激肽b1受体拮抗剂的用途 |
| WO2012028331A1 (en) | 2010-09-03 | 2012-03-08 | Grünenthal GmbH | Substituted tetrahydropyrrolopyrazine derivatives |
| KR20190120458A (ko) | 2010-10-21 | 2019-10-23 | 메디베이션 테크놀로지즈 엘엘씨 | 결정질의 (8s,9r)-5-플루오로-8-(4-플루오로페닐)-9-(1-메틸-1h-1,2,4-트리아졸-5-일)-8,9-디하이드로-2h-피리도[4,3,2-de]프탈라진-3(7h)-온 토실레이트 염 |
| EA201790290A1 (ru) * | 2014-07-31 | 2017-07-31 | Медивэйшн Текнолоджиз, Инк. | Формерные соли (2s,3s)-метил 7-фтор-2-(4-фторфенил)-3-(1-метил-1h-1,2,4-триазол-5-ил)-4-оксо-1,2,3,4-тетрагидрохинолин-5-карбоксилата и способы их получения |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7521457B2 (en) * | 2004-08-20 | 2009-04-21 | Boehringer Ingelheim International Gmbh | Pyrimidines as PLK inhibitors |
| DE102006039003A1 (de) * | 2006-08-19 | 2008-02-21 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Verbindungen |
| JP5603770B2 (ja) * | 2007-05-31 | 2014-10-08 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ccr2受容体拮抗薬およびその使用 |
| EP2025675A1 (de) * | 2007-08-14 | 2009-02-18 | Boehringer Ingelheim International GmbH | Arylsulfonamide mit analgetischer Wirkung |
| EP2188269B1 (de) * | 2007-08-14 | 2014-05-07 | Boehringer Ingelheim International GmbH | Arylsulfonamide mit analgetischer wirkung |
| US8207335B2 (en) * | 2009-02-13 | 2012-06-26 | Boehringer Ingelheim International Gmbh | Process for making certain compounds having B1 antagonistic activity |
-
2009
- 2009-02-13 KR KR1020117003168A patent/KR20110053424A/ko not_active Withdrawn
- 2009-02-13 US US13/058,658 patent/US20110301350A1/en not_active Abandoned
- 2009-02-13 MX MX2011001563A patent/MX2011001563A/es not_active Application Discontinuation
- 2009-02-13 CA CA2735560A patent/CA2735560A1/en not_active Abandoned
- 2009-02-13 WO PCT/EP2009/001012 patent/WO2010017850A1/de not_active Ceased
- 2009-02-13 JP JP2011522388A patent/JP2011530544A/ja active Pending
- 2009-02-13 BR BRPI0914556-7A patent/BRPI0914556A2/pt not_active IP Right Cessation
-
2011
- 2011-01-19 IL IL210741A patent/IL210741A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2011530544A (ja) | 2011-12-22 |
| US20110301350A1 (en) | 2011-12-08 |
| KR20110053424A (ko) | 2011-05-23 |
| MX2011001563A (es) | 2011-03-04 |
| CA2735560A1 (en) | 2010-02-18 |
| IL210741A0 (en) | 2011-03-31 |
| WO2010017850A1 (de) | 2010-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0911254A2 (pt) | processo para a preparação de um composto | |
| BRPI0816258A2 (pt) | processo para a preparação de compostos úteis como inibidores de sglt | |
| BRPI0910916A2 (pt) | Processo para a produção de um dianidroaçúcar | |
| BRPI0920356A2 (pt) | Processo para a preparação de compostos úteis como inibidores de sglt | |
| BRPI0916609A2 (pt) | Processo para a preparação de um macrociclo | |
| BR112012014490A2 (pt) | processo para a preparação substituída de 1-o-acil-2-desóxi-2-fluoro-4-tio-beta-d-arabinofuranoses | |
| BRPI0910910A2 (pt) | processo para preparar um composto | |
| BRPI0910911A2 (pt) | processo para preparar um composto | |
| BRPI0923180A2 (pt) | processo para a produção de produtos químicos | |
| BRPI0915572A2 (pt) | processo para a fabricação de epicloroidrina | |
| BRPI1013561A2 (pt) | Processo para a preparação de alogliptina | |
| BRPI1012370A2 (pt) | processo para a produção de olefinas | |
| BRPI0914788A2 (pt) | Processo para a produção de um produto intermediário de etexilato de dabigatran | |
| BRPI0911897A2 (pt) | Processo para a preparação de compostos, e, composto | |
| BRPI1013830A2 (pt) | Processo para a iodação de compostos aromáticos | |
| BRPI0817747A2 (pt) | Processo para a preparação de derivados de ácido 2-di-halogenoacil-3-amino-acrílico | |
| BRPI0909393A2 (pt) | processo para a preparação de polibutadieno | |
| BRPI0921420A2 (pt) | processo para preparar compostos | |
| BRPI0914556A2 (pt) | Processo para a preparação de compostos de piperazina substituídos por cicloalquila | |
| BRPI1008117A2 (pt) | Processo para a sintese de cleistantina | |
| BRPI0821837A2 (pt) | Processo para a preparação de 6-substituídas-1-(2h)-isoquinolinonas | |
| BRPI0911992A2 (pt) | processo para preparação de bifenilanilidas substituídas | |
| BRPI0811315A2 (pt) | Processo para a preparação de um composto | |
| BR112012001731A2 (pt) | Processo para a preparação de 1-benzil-3-hidroximetil-1h-indazol | |
| BRPI0920705A2 (pt) | processo para a produção de compostos aquilaromáticos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 4A, 5A E 6A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |